Klotho Neuroscience (KLTO) Cash From Financing

Annual CFF

$500.00 K
+$250.00 K+100.00%

December 1, 2022

Summary

Performance

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

15-Year Change

+100%

KLTO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.2%
KLTO annual cash flow from financing activities is higher than 33.2% of companies in Healthcare sector

High & Low

All-time High

$500.00 K
KLTO annual cash flow from financing activities is currently at an all-time high

3-Year Low

$250.00 K
KLTO annual cash flow from financing activities is currently +100.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2022
KLTO previous annual earnings announcement was published on Dec 1, 2022

Next Annual Earnings Report Date

N/A
KLTO next annual earnings announcement has not yet been scheduled

OtherKLTOcash flowmetrics:

Annual CFI

-$125.40 K
KLTO annual cash flow from investing activities is -$125.40 thousand

Annual CFO

-$599.60 K
KLTO annual cash flow from operations is -$599.60 thousand

Annual FCF

-$725.00 K
KLTO annual free cash flow is -$725.00 thousand

Annual CAPEX

-
KLTO annual capital expenditures value is unknown

Quarterly CFF

$278.50 K
-$1.44 M-83.81%

September 1, 2024

Summary

Performance

3-Month Change

-83.81%

1-Year Change

-

3-Year Change

-

5-Year Change

-

KLTO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.06%
KLTO quarterly cash flow from financing activities is higher than 56.06% of companies in Healthcare sector

High & Low

All-time High

$1.72 M
KLTO quarterly cash flow from financing activities is currently -83.81% below its historical high of $1.72 million

3-Year Low

$175.00 K
KLTO quarterly cash flow from financing activities is currently +59.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
KLTO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
KLTO next earnings announcement has not yet been scheduled

OtherKLTOcash flowmetrics:

Quarterly CFI

$0.00
KLTO quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$1.07 M
KLTO quarterly cash flow from operations is -$1.07 million

Quarterly FCF

-$1.07 M
KLTO quarterly free cash flow is -$1.07 million

Quarterly CAPEX

-
KLTO quarterly capital expenditures value is unknown

TTM CFF

$2.17 M
+$278.50 K+14.69%

September 1, 2024

Summary

Performance

3-Month Change

+14.69%

1-Year Change

-

3-Year Change

-

5-Year Change

-

KLTO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.62%
KLTO TTM cash flow from financing activities is higher than 36.62% of companies in Healthcare sector

High & Low

All-time High

$2.17 M
KLTO TTM cash flow from financing activities is currently at an all-time high

3-Year Low

$250.00 K
KLTO TTM cash flow from financing activities is currently +769.56% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
KLTO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
KLTO next earnings announcement has not yet been scheduled

OtherKLTOcash flowmetrics:

TTM CFI

-$123.50 K
KLTO TTM cash flow from investing activities is -$123.50 thousand

TTM CFO

-$2.00 M
KLTO TTM cash flow from operations is -$2.00 million

TTM FCF

-$2.13 M
KLTO TTM free cash flow is -$2.13 million

TTM CAPEX

-
KLTO TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

KLTO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%--
3 y3 years+100.0%--
5 y5 years+100.0%--

KLTO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.0%-83.8%+59.1%at high+769.6%
5 y5-yearat high+100.0%-83.8%+59.1%at high+769.6%
alltimeall timeat high+100.0%-83.8%+59.1%at high+769.6%

Klotho Neuroscience Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$278.50 K(-83.8%)
$2.17 M(+14.7%)
Jun 2024
-
$1.72 M(+883.1%)
$1.90 M(+346.0%)
Mar 2024
-
$175.00 K(-30.0%)
$425.00 K(+70.0%)
DateAnnualQuarterlyTTM
Jun 2023
-
$250.00 K(0.0%)
$250.00 K(0.0%)
Dec 2022
$500.00 K(+100.0%)
-
-
Jun 2022
-
$250.00 K
$250.00 K
Dec 2021
$250.00 K
-
-

FAQ

  • What is Klotho Neuroscience annual cash flow from financing activities?
  • What is the all time high annual CFF for Klotho Neuroscience?
  • What is Klotho Neuroscience annual CFF year-on-year change?
  • What is Klotho Neuroscience quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Klotho Neuroscience?
  • What is Klotho Neuroscience TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Klotho Neuroscience?

What is Klotho Neuroscience annual cash flow from financing activities?

The current annual CFF of KLTO is $500.00 K

What is the all time high annual CFF for Klotho Neuroscience?

Klotho Neuroscience all-time high annual cash flow from financing activities is $500.00 K

What is Klotho Neuroscience annual CFF year-on-year change?

Over the past year, KLTO annual cash flow from financing activities has changed by +$250.00 K (+100.00%)

What is Klotho Neuroscience quarterly cash flow from financing activities?

The current quarterly CFF of KLTO is $278.50 K

What is the all time high quarterly CFF for Klotho Neuroscience?

Klotho Neuroscience all-time high quarterly cash flow from financing activities is $1.72 M

What is Klotho Neuroscience TTM cash flow from financing activities?

The current TTM CFF of KLTO is $2.17 M

What is the all time high TTM CFF for Klotho Neuroscience?

Klotho Neuroscience all-time high TTM cash flow from financing activities is $2.17 M